Ninth Circuit Upholds FDA’s Authority to Regulate Stem Cell Clinic Treatments
FDA Law
OCTOBER 14, 2024
(Note we do not discuss the cell expansion variety of this treatment further in this blog as the court quickly dispensed of it as obviously not subject to the SSP exception.) These procedures are offered to treat a variety of conditions, including Alzheimer’s, arthritis, asthma, cancer, etc., 21 U.S.C. §
59 
Let's personalize your content